Metabolic engineering of Escherichia coli for resveratrol production using food-grade D-xylose as a carbon source
Journal of Industrial Microbiology and Biotechnology · 08.01.2026 · 53
DOI: 10.1093/jimb/kuag017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Industrial Microbiology and Biotechnology, online erschienen am 02.07.2026. Verfasst von Huy Quang Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Enzyme and Protein Technology, Faculty of Biology, University of Science, Vietnam National University, Hanoi (VNU), 334 Ng…. Hauptthemen laut MEDLINE: Escherichia coli, Xylose, Metabolic Engineering, Stilbenes. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vietnam National University, Hanoi.
Abstract (Originalsprache)
Resveratrol is a high-value polyphenolic compound widely utilized in nutraceutical, cosmetic, and pharmaceutical applications. However, most microbial production systems rely on glucose as the primary carbon source, which limits flexibility for integrating alternative and renewable feedstocks. In this study, we developed an engineered Escherichia coli platform to investigate resveratrol biosynthesis under xylose-supporting conditions, using food-grade D-xylose as the carbon source. A heterologous pathway consisting of Populus tomentosa 4-coumarate: CoA ligase (Pt4CL) and Arachis hypogaea stilbene synthase (AhSTS) was introduced to convert externally supplied p-coumaric acid (PCA) into resveratrol. To improve precursor availability, intracellular malonyl-CoA supply was enhanced by introducing matB and matC from Streptomyces coelicolor A3(2) and overexpressing the acetyl-CoA carboxylase complex (ACC) from E. coli. Xylose assimilation was further strengthened by expressing xylE, xylA, and xylB, while carbon catabolite repression was alleviated using CRISPR interference (CRISPRi) targeting the glucose transporter gene ptsG. Under shake-flask conditions, the engineered strain produced up to 23.9 mg/L resveratrol from food-grade D-xylose, accompanied by near-complete xylose consumption and 93%–94% precursor conversion. This corresponded to an overall fermentation yield of approximately 12.5 mg resveratrol per g xylose consumed. Similar titers (27 mg/L) were obtained in a 5-L bioreactor, indicating stable pathway performance under controlled fermentation conditions. Overall, these results show that E. coli can be engineered to support efficient precursor-to-product conversion under xylose-supported conditions, providing a useful proof-of-concept framework for integrating alternative carbon sources into microbial production platforms for aromatic compounds. One sentence summary An engineered Escherichia coli system integrates xylose utilization, malonyl-CoA pathway optimization, and CRISPRi regulation to support resveratrol biosynthesis under xylose-supported conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Enzyme and Protein Technology, Faculty of Biology, University of Science, Vietnam National University, Hanoi (VNU), 334 Nguyen Trai, Thanh Xuan, Hanoi 10000, Vietnam.
ORCID-Profile: Hoa An Thi Nguyen, Luan Luong Chu
Förderung
- Vietnam National University, Hanoi
Zitieren
APA
Nguyen, H. Q., Nguyen, H. A. T., & Chu, L. L. (2026). Metabolic engineering of Escherichia coli for resveratrol production using food-grade D-xylose as a carbon source. Journal of Industrial Microbiology and Biotechnology, 53. https://doi.org/10.1093/jimb/kuag017
Vancouver
Nguyen HQ, Nguyen HAT, Chu LL. Metabolic engineering of Escherichia coli for resveratrol production using food-grade D-xylose as a carbon source. Journal of Industrial Microbiology and Biotechnology. 2026;53. doi:10.1093/jimb/kuag017
BibTeX
@article{Nguyen2026,
author = {Nguyen, Huy Quang and Nguyen, Hoa An Thi and Chu, Luan Luong},
title = {Metabolic engineering of Escherichia coli for resveratrol production using food-grade D-xylose as a carbon source},
journal = {Journal of Industrial Microbiology and Biotechnology},
year = {2026},
volume = {53},
doi = {10.1093/jimb/kuag017}
}
EUVIMED